Cargando…
Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment
A 19-year-old girl was diagnosed with type 1 diabetes and showing polydipsia and polyuria. She was double autoantibody-positive and had a diabetes-prone tissue type. She was immediately started on insulin. Fenofibrate treatment (160 mg daily) was initiated seven days after diagnosis. The need for in...
Autores principales: | Buschard, Karsten, Holm, Laurits J., Feldt-Rasmussen, Ulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245672/ https://www.ncbi.nlm.nih.gov/pubmed/32508930 http://dx.doi.org/10.1155/2020/6865190 |
Ejemplares similares
-
Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice
por: Holm, Laurits J., et al.
Publicado: (2019) -
L‐serine: a neglected amino acid with a potential therapeutic role in diabetes
por: Holm, Laurits J., et al.
Publicado: (2019) -
PPARs and the Development of Type 1 Diabetes
por: Holm, Laurits J., et al.
Publicado: (2020) -
Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19
por: Buschard, Karsten
Publicado: (2020) -
Possible Prevention of Diabetes with a Gluten-Free Diet
por: Haupt-Jorgensen, Martin, et al.
Publicado: (2018)